COVID-19 may have an impact on people’s cognitive and memory abilities that lasts a year or more after infection. A new study by Imperial College London researchers reveals small deficits in the performance of cognitive and memory tasks in people who had recovered from COVID-19 compared with those who had not had COVID-19. This includes […]
Read More… from COVID-19’s Lasting Impact on Cognition and Memory
Israel’s Rambam Hospital Joins Efforts to Develop Israeli COVID-19 Vaccine: Israel currently has the highest COVID-19 vaccination rate in the world, and the vast majority of Rambam’s approximately 5,300 employees have already received two doses of the Pfizer vaccine. Earlier this month, the Clinical Trials Unit at Rambam Health Care Campus (in Rambam’s Research & Development […]
Read More… from Israel’s Rambam Hospital Joins Efforts to Develop Israeli COVID-19 Vaccine
ESCP strikes new global research partnership with CovidSurg to explore the effects of COVID-19 in surgery. COVID-19 is a rapidly expanding global challenge, placing a huge burden on healthcare systems. There is no evidence to inform the management of surgical patients with COVID-19 infection. Sharing international experience is vital to inform the management of this […]
Webinar for Integrated Crisis Management in the NHS for COVID-19. David Nott (War, Disaster and Trauma Surgeon), Shanu Rasheed (experienced in complex surgery and disaster response) & Dominic Morgan (paramedic experienced in command structure and disaster response) discuss how crisis management must be integrated into the NHS if we are to avoid a further peak […]
Read More… from Webinar – Integrated Crisis Management in the NHS for Covid-19
Chloroquine was shown in 2004 to be active in vitro against SARS coronavirus but is of unproven efficacy and safety in patients infected with SARS-CoV-2. The drug’s potential benefits and risks for COVID-19 patients, without and with azithromycin, is discussed by Dr. David Juurlink, head of the Division of Clinical Pharmacology and Toxicology at Sunnybrook […]
Read More… from COVID-19 Update: Chloroquine / Hydroxychloroquine and Azithromycin
Anthony Stephen Fauci is an American immunologist who serves as director of the National Institute of Allergy and Infectious Diseases and as a member of the White House Coronavirus Task Force addressing the 2019–20 coronavirus pandemic. […]